Amphastar Pharmaceuticals, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +6.7% | +14.9% | +0.2% | +9.6% | +6.3% | +13.0% | +14.3% | +7.5% | +6.4% | +10.5% | +103.9% | +4.3% | +3.3% | |
| – | – | – | +4.4% | +14.5% | -11.1% | +4.6% | +2.0% | +17.3% | +15.8% | +9.6% | +13.7% | +18.9% | +29.4% | +9.1% | +19.1% | |
| – | – | – | +6.7% | +26.6% | -2.6% | +9.5% | -9.3% | +31.6% | -12.5% | +22.6% | +36.4% | +23.5% | -7.6% | +5.1% | +12.2% | |
| – | – | – | +6.7% | +26.6% | -2.6% | +10.3% | -6.4% | +30.7% | +0.4% | +18.0% | +29.4% | +28.6% | +46.1% | -13.7% | +27.6% | |
| – | – | – | -35.8% | -7.0% | +45.4% | -19.4% | +34.4% | +44.9% | -13.0% | +45.5% | +19.4% | +12.7% | +30.0% | +19.5% | +4.0% | |
| – | – | – | +36.1% | +17.8% | -14.2% | +12.9% | -20.2% | +9.0% | +59.4% | -12.4% | -4.2% | +11.6% | +2.2% | +45.3% | +15.1% | |
| – | – | – | +8.6% | +18.6% | +2.8% | +7.6% | +21.2% | +13.5% | +11.1% | +11.2% | -6.1% | -2.4% | – | – | – | |
| – | – | – | +0.0% | +1,495.4% | -16.6% | +6.7% | +12.2% | -11.4% | -8.0% | +8.4% | -15.9% | -5.6% | +2.9% | -5.2% | +11.6% | |
| – | – | – | -5.2% | -4.5% | -5.0% | +28.1% | -12.2% | -5.8% | -2.1% | -2.2% | -3.0% | -3.9% | +1,685.3% | -3.7% | -4.3% | |
| – | – | – | +3.8% | +23.3% | -12.0% | +4.1% | +19.1% | +27.2% | +6.9% | +14.5% | +23.8% | -5.6% | +309.5% | -3.2% | -0.6% | |
| – | – | – | +8.9% | -4.3% | -4.2% | +1.1% | +10.8% | +59.0% | -15.7% | +24.7% | -7.5% | -8.6% | +137.6% | -22.9% | -9.0% | |
| – | – | – | +0.2% | -65.6% | +44.0% | -50.9% | +17.6% | +188.8% | -40.1% | +43.1% | -66.8% | +16.7% | -28.2% | +62.1% | +36.0% | |
| – | – | – | +15.4% | -50.1% | +36.5% | +43.7% | -16.6% | +88.4% | -20.0% | -2.8% | -8.8% | -7.7% | +24.1% | +20.0% | +6.8% | |
| – | – | – | -36.9% | +258.6% | -16.5% | +7.3% | +26.2% | -21.7% | +23.2% | -13.2% | +118.7% | -2.6% | +709.4% | +2.0% | +1.2% | |
| – | – | – | +7.8% | +12.1% | +4.8% | +11.4% | +2.5% | -1.5% | +14.7% | +5.5% | +10.7% | +18.7% | +21.0% | +14.5% | +7.7% | |
| – | – | – | +19.1% | -14.5% | -4.4% | +17.5% | +7.6% | -11.5% | +72.4% | +1.2% | +53.1% | +50.7% | +50.6% | +39.0% | +17.2% | |
| – | -79.5% | +0.0% | +0.0% | +424.5% | +7.2% | +5.7% | +1.8% | -4.1% | +7.6% | -1.6% | +1.3% | +5.3% | +1.1% | -1.8% | -7.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.